Lifecore Biomedical, Inc. (LFCR)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$5.44
+1.31%
Mkt Cap $261.51M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+10.3%
Consensus $6.00 vs current $5.44